SHR-1819

DRUG4 trials

Sponsors

Atridia Pty Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Guangdong Hengrui Pharmaceutical Co., Ltd

Conditions

AsthmaHealthy VolunteersModerate to Severe Atopic Dermatitis

Phase 1

A Trial of SHR-1819 in Healthy Subjects

CompletedNCT04561128

Atridia Pty Ltd.Healthy Volunteers

Start: 2020-11-01End: 2022-03-07Updated: 2022-07-12

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects

CompletedNCT04772365

Shanghai Hengrui Pharmaceutical Co., Ltd.Asthma

Start: 2021-03-01End: 2021-12-10Updated: 2022-11-29

Phase 2

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

CompletedNCT05549947

Shanghai Hengrui Pharmaceutical Co., Ltd.Moderate to Severe Atopic Dermatitis

Start: 2022-10-08End: 2023-11-23Updated: 2026-04-29

Phase 3

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

CompletedNCT06468956

Guangdong Hengrui Pharmaceutical Co., LtdModerate to Severe Atopic Dermatitis

Start: 2024-06-14End: 2026-08-26Updated: 2026-09-03